These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1081 related articles for article (PubMed ID: 6323226)
1. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs. McCaa RE; Gillespie JB Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226 [TBL] [Abstract][Full Text] [Related]
2. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure. McCaa RE Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146 [TBL] [Abstract][Full Text] [Related]
3. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system. McCaa RE Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367 [TBL] [Abstract][Full Text] [Related]
4. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency. McCaa RE Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226 [TBL] [Abstract][Full Text] [Related]
5. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems. Ohman KP; Karlberg BE; Nilsson OR; Wettre S Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190 [TBL] [Abstract][Full Text] [Related]
6. The influence of sodium intake on physiological responses to angiotensin II in conscious dogs. Olsen ME; Meydrech EF Scand J Urol Nephrol Suppl; 1984; 79():29-34. PubMed ID: 6089315 [TBL] [Abstract][Full Text] [Related]
7. [Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system]. Jover B; Dupont M; Casellas D; Mimran A Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1234-7. PubMed ID: 6098235 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure. Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609 [TBL] [Abstract][Full Text] [Related]
9. Physiological responses to angiotensin II infusion during chronic angiotensin converting enzyme inhibition in dogs on normal, low and high sodium intake. Olsen ME; Meydrech EF J Hypertens; 1985 Oct; 3(5):517-25. PubMed ID: 2999230 [TBL] [Abstract][Full Text] [Related]
10. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects. Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164 [TBL] [Abstract][Full Text] [Related]
11. Studies in vivo with angiotensin I converting enzyme (kininase II) inhibitors. McCaa RE Fed Proc; 1979 Dec; 38(13):2783-7. PubMed ID: 228990 [No Abstract] [Full Text] [Related]
12. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep. Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038 [TBL] [Abstract][Full Text] [Related]
13. Renin--angiotensin antagonists and the regulation of blood pressure. Samuels AI; Miller ED; Fray JC; Haber E; Barger AC Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095 [TBL] [Abstract][Full Text] [Related]
14. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension. Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326 [TBL] [Abstract][Full Text] [Related]
15. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition. Clappison BH; Anderson WP; Johnston CI Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229 [TBL] [Abstract][Full Text] [Related]
16. Crossover comparison of the effects of enalapril and captopril on potassium homeostasis in patients with mild hypertension. Ohya Y; Ueno M; Takata Y; Tominaga M; Ohmori S; Kobayashi K; Abe I; Fujishima M Int J Clin Pharmacol Ther; 1994 Dec; 32(12):655-9. PubMed ID: 7881704 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects. Laubie M; Schiavi P; Vincent M; Schmitt H J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763 [TBL] [Abstract][Full Text] [Related]
18. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats. Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of the blood pressure and renal hemodynamic effects of captopril. Hall JE; Granger JP Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591 [TBL] [Abstract][Full Text] [Related]
20. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension]. Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]